Docusign Inc. (NASDAQ:DOCU – Get Free Report) insider James Shaughnessy sold 7,500 shares of the business’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total value of $533,925.00. Following the completion of the sale, the insider directly owned 55,442 shares of the company’s stock, valued at approximately $3,946,915.98. This trade represents a 11.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Docusign Price Performance
DOCU opened at $69.73 on Friday. The stock’s 50 day simple moving average is $76.17 and its 200 day simple moving average is $79.04. Docusign Inc. has a 1 year low of $62.66 and a 1 year high of $107.86. The firm has a market cap of $14.02 billion, a price-to-earnings ratio of 52.43, a PEG ratio of 3.47 and a beta of 1.02.
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The business’s revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, sell-side analysts anticipate that Docusign Inc. will post 1.17 EPS for the current year.
Analyst Ratings Changes
Check Out Our Latest Research Report on Docusign
Hedge Funds Weigh In On Docusign
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wealth Enhancement Advisory Services LLC raised its stake in shares of Docusign by 17.9% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 17,215 shares of the company’s stock worth $1,548,000 after purchasing an additional 2,612 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in Docusign by 153.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company’s stock worth $37,000 after buying an additional 274 shares in the last quarter. GAMMA Investing LLC raised its position in Docusign by 35,572.1% in the 1st quarter. GAMMA Investing LLC now owns 286,447 shares of the company’s stock worth $23,317,000 after buying an additional 285,644 shares during the last quarter. Parallel Advisors LLC lifted its stake in Docusign by 71.8% during the 1st quarter. Parallel Advisors LLC now owns 4,764 shares of the company’s stock valued at $388,000 after acquiring an additional 1,991 shares during the period. Finally, RFG Advisory LLC bought a new position in Docusign during the 1st quarter valued at about $274,000. 77.64% of the stock is owned by institutional investors.
Docusign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than Docusign
- EV Stocks and How to Profit from Them
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- How to Use Stock Screeners to Find Stocks
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.